Profound_Logo_CMYK copy.jpg
Profound Medical Announces Fourth Quarter and Full Year 2023 Financial Results
March 07, 2024 16:05 ET | Profound Medical Corp.
TORONTO, March 07, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
Profound_Logo_CMYK copy.jpg
Profound Medical to Participate in Barclays 26th Annual Global Healthcare Conference
March 04, 2024 16:30 ET | Profound Medical Corp.
TORONTO, March 04, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
Profound_Logo_CMYK copy.jpg
Profound Medical in Collaboration with Siemens Healthineers to Further Expand Physician and Patient Access to the TULSA Procedure
February 27, 2024 07:45 ET | Profound Medical Corp.
TORONTO, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
Profound_Logo_CMYK copy.jpg
Profound Medical to Release Fourth Quarter and Full Year 2023 Financial Results on March 7 – Conference Call to Follow
February 15, 2024 16:30 ET | Profound Medical Corp.
TORONTO, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
Profound_Logo_CMYK copy.jpg
Profound Medical Announces Non-Brokered Private Placement
January 16, 2024 16:30 ET | Profound Medical Corp.
TORONTO, Jan. 16, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX:PRN; NASDAQ:PROF) ("Profound" or the "Company") is pleased to announce that the Company has entered into subscription...
Profound_Logo_CMYK copy.jpg
Profound Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Revenues
January 03, 2024 16:15 ET | Profound Medical Corp.
TORONTO, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
Profound_Logo_CMYK copy.jpg
Profound Medical Announces Pricing of US$20 Million Public Offering of Common Shares
December 27, 2023 22:40 ET | Profound Medical Corp.
TORONTO, Dec. 27, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX:PRN; NASDAQ:PROF) (“Profound” or the “Company”) today announced the pricing of its previously announced underwritten public...
Profound_Logo_CMYK copy.jpg
Profound Medical Announces Proposed Public Offering of Common Shares
December 27, 2023 16:15 ET | Profound Medical Corp.
TORONTO, Dec. 27, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX:PRN; NASDAQ:PROF) (“Profound” or the “Company”) is pleased to announce the commencement of an underwritten public offering in...
Profound_Logo_CMYK copy.jpg
Profound Medical to Participate in the Stifel 2023 Healthcare Conference
November 08, 2023 07:45 ET | Profound Medical Corp.
TORONTO, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
Profound_Logo_CMYK copy.jpg
Profound Medical Announces CMS Extension of Temporary ‘Code’ for TULSA to ASC Setting
November 03, 2023 08:00 ET | Profound Medical Corp.
TORONTO, Nov. 03, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...